Tanja Holopainen

发表

Vascular Endothelial Growth Factor-Angiopoietin Chimera With Improved Properties for Therapeutic Angiogenesis

Eun Chun Han, Chulhee Choi, K. Alitalo, 2013, Circulation.

Assessment of tumour viability in human lung cancer xenografts with texture-based image analysis

K. Alitalo, N. Linder, Riku Turkki, 2015, Journal of Clinical Pathology.

Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation

K. Alitalo, S. Ylä-Herttuala, T. Petrova, 2007, Nature Medicine.

endothelial growth factor Notch restricts lymphatic vessel sprouting induced by vascular

K. Alitalo, Masahiro Yamamoto, T. Karpanen, 2011 .

Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor.

K. Alitalo, Masahiro Yamamoto, S. Ylä-Herttuala, 2011, Blood.

The Basis for the Distinct Biological Activities of Vascular Endothelial Growth Factor Receptor–1 Ligands

K. Alitalo, M. Jeltsch, A. Anisimov, 2013, Science Signaling.

Molecular Targeting of Lymphangiogenesis and Tumor Metastasis

K. Alitalo, C. Heckman, Tanja Holopainen, 2009 .

MMP16 Mediates a Proteolytic Switch to Promote Cell-Cell Adhesion, Collagen Alignment, and Lymphatic Invasion in Melanoma.

K. Alitalo, S. Hautaniemi, R. Louhimo, 2015, Cancer research.

Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis

K. Alitalo, P. Saharinen, S. Ylä-Herttuala, 2012, Journal of the National Cancer Institute.

Photodynamic Ablation of Lymphatic Vessels and Intralymphatic Cancer Cells Prevents Metastasis

I. Immonen, K. Alitalo, L. Andersson, 2011, Science Translational Medicine.

Loss of Bmx Nonreceptor Tyrosine Kinase Prevents Pressure Overload–Induced Cardiac Hypertrophy

T. Vondriska, K. Alitalo, Yibin Wang, 2008, Circulation research.

Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses

F. Penna, O. Ritvos, J. Hulmi, 2018, Journal of cachexia, sarcopenia and muscle.

endothelial cell junctions Angiopoietin 2 regulates the transformation and integrity of lymphatic Material Supplemental

Sila Appak, H. Augustin, K. Alitalo, 2014 .

Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions

Sila Appak, H. Augustin, K. Alitalo, 2014, Genes & development.

The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.

K. Alitalo, S. Wedge, S. Ylä-Herttuala, 2008, Cancer research.

CCBE1 Enhances Lymphangiogenesis via ADAMTS3-Mediated VEGF-C Activation

K. Alitalo, S. Ortega, M. Jeltsch, 2014 .

Tuomas Tammela Cells Prevents Metastasis Photodynamic Ablation of Lymphatic Vessels and Intralymphatic Cancer

I. Immonen, K. Alitalo, L. Andersson, 2011 .

Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth.

K. Alitalo, D. Hicklin, Takashi Takahashi, 2007, Cancer research.

CCBE1 Enhances Lymphangiogenesis via A Disintegrin and Metalloprotease With Thrombospondin Motifs-3–Mediated Vascular Endothelial Growth Factor-C Activation

K. Alitalo, S. Ortega, M. Jeltsch, 2014, Circulation.

Deletion of the endothelial Bmx tyrosine kinase decreases tumor angiogenesis and growth.

W. Min, K. Alitalo, L. Andersson, 2012, Cancer research.

Prox1 promotes expansion of the colorectal cancer stem cell population to fuel tumor growth and ischemia resistance.

K. Alitalo, C. Haglund, Y. Ben-Neriah, 2014, Cell reports.

Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels.

K. Alitalo, Takashi Takahashi, M. Jeltsch, 2005, Cancer research.

Endothelial Bmx tyrosine kinase activity is essential for myocardial hypertrophy and remodeling

K. Alitalo, T. Tuomainen, L. Andersson, 2015, Proceedings of the National Academy of Sciences.

Perspectives on lymphangiogenesis and angiogenesis in cancer

K. Alitalo, M. Bry, A. Saaristo, 2011, Journal of surgical oncology.

Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy.

Lauri Eklund, Friedemann Kiefer, Andrey Anisimov, 2014, The Journal of clinical investigation.

Vascular Endothelial Growth Factor-B Acts as a Coronary Growth Factor in Transgenic Rats Without Inducing Angiogenesis, Vascular Leak, or Inflammation

P. Carmeliet, M. Shibuya, K. Alitalo, 2010, Circulation.

Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination and metastasis establishment.

K. Alitalo, G. Koh, Jun Wu, 2009, Cancer research.

Elevated VEGF-D Modulates Tumor Inflammation and Reduces the Growth of Carcinogen-Induced Skin Tumors1

K. Alitalo, T. Pihlajaniemi, R. Heljasvaara, 2016, Neoplasia.

Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization.

K. Alitalo, H. Lankinen, W. Holnthoner, 2010, Cancer cell.

[Prox1 promotes expansion of the colorectal cancer stem cell population to fuel tumor growth and ischemia resistance].

K. Alitalo, C. Haglund, Y. Ben-Neriah, 2014, Duodecim; laaketieteellinen aikakauskirja.

Hypertrophy Induced Cardiac - Loss of Bmx Nonreceptor Tyrosine Kinase Prevents Pressure Overload

T. Vondriska, K. Alitalo, Yibin Wang, 2013 .